Nov. 28, 2021 Updated 
In response to the progress of bioscience in recent years, growing attention has been paid to the materials, named biomaterials, that interact with a living body or its composition elements like proteins or the cells, and so on. Many of such biomaterials were already put to practical use with the high-tech devices as central materials, such as artificial organs, drug delivery system and biosensors. In addition, the research and development of new biomaterials are actively carried out all around the world, e.g the material whose structures and functions are changed responding to external stimuli (Intelligent materials) or those who are guiding the proliferation and differentiation of the cells.
------by Kazunori Kataoka From 'Biomaterial Engineering' (Publisher, Shokabo)

Innovation Center of NanoMedicine (iCONM)
3-25-14 Tono-machi, Kawasaki, Kanagawa, 210-0821 Access Map

11/28/2021
Professor Kazunori Kataoka, Director General of iCONM, has been selected to a 2021 Highly Cited Researcher in Clarivate Analytics (Web of Scinece), recognized for his exceptional research influence demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in Web of Science.
List of 2021 Highly Cited Researchers
Researcher Page (Kazunori Kataoka)
10/12/2021
The Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, in collaboration with the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, has succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificality in treating orthotopically transplanted mice with glioblastoma (GBM), A press seminar was held.
Conjugation of glucosylated polymer chains to checkpoint-blockade antibodies augment their efficacy and specificity for glioblastoma
▶(10/06) Press Release
悪性脳腫瘍の中で特異的に活性化し、副作用なく治療を行う免疫チェックポイント阻害抗体の開発に成功
▶(10/11) EurekAlert!
Antibody delivery technology empowers immunotherapy against glioblastoma and suppresses side effects
▶(10/11) ScienMag
Antibody delivery technology empowers immunotherapy against glioblastoma and suppresses side effects
10/08/2021
Innovation Center of NanoMedicine in collaboration with the Chinese Academy of Science (CAS) Key Laboratory of Soft Matter Chemistry (USTC: University of Science and Technology), has created nanomachines that detect MMPs (matrix metalloproteinases), a principal enzyme for cancer cells to invade normal tissue, and deliver anticancer drugs according to an announcement in the journal Advanced Materials (IF = 30.849).
Enzymatically transformable polymersome-based nanotherapeutics to eliminate minimal relapsable cancer
▶(10/08) Press Release
手術後の浸潤性の高いがんを検出し再発を予防する高分子ナノソームの創出〜がんの転移・再発の予防
▶(10/13) Mirage News
Creating smart nanomachines to detect highly invasive cancer after surgery and prevent recurrence - cancer metastasis and recurrence
▶(10/12) EurekAlert!
Creating smart nanomachines to detect highly invasive cancer after surgery and prevent recurrence - cancer metastasis and recurrence prevention
08/11/2021
An article about our research "Nano-micelle Packaging CRISPR/Cas9 Components Enables Brain Genome Editing” was posted on TriLink BYOTECHNOLOGIES.
▶ (07/20) TriLink BYOTECHNOLOGIES
CleanCapR IVT Cas9 mRNA in Micelles Used for Genome Editing in Mouse Brain for the First Time
08/04/2021
An Article of JST NEWS (published on June) was published in Science Japan website.
▶ (08/04) Early Detection and Treatment Facilitated Using Nanomachines: Guaranteed Health
08/03/2021
Innovation Center of NanoMedicine and the International University of Catalunya jointly announced that Polymeric Nanomicelles Improve Internalization of Lipid Metabolism Modulators in Brain Cells.
Press release
▶ (08/03) EurekAlert!
▶ (08/04) Pharm Tech Japan Online
▶ (08/04) 医薬通信社 (Japanese)
▶ (08/05) 日本の研究.com (Japanese)
▶ (08/11) 日刊工業新聞電子版 (Japanese)
▶ (08/16) 化学工業日報 4 面
iCONM - カタルーニャ国際大 脂質代謝を抑制 薬物送達技術を開発 (Japanese)
▶ (09/03) AZO NANO
07/26/2021
Dr. Yasutaka ANRAKU (Project Associate Professor, Dept. of Bioengineering, Graduate School of Engineering, The University of Tokyo) was appeared NHK World “Medical Frontiers” and explained nanomachines with the ability to deliver drug into the brain.
(NHK World) Tackling Dementia After Onset
07/15/2021
An article about the press release on 4/20 "Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex" was published in Science Japan.
▶ (07/15) Development of innovative nucleic acid drugs effective against refractory breast and pancreatic cancers
07/02/2021
An Article of JST NEWS (published on June) was published in 客観日本 website.
▶ (07/02) “纳米机器”开拓新医疗方式,通过早期发现和治疗实现人人健康的社会 (Chinese)